News - Markets & Marketing, Management

Filter

Popular Filters

1 to 25 of 32 results

GSK comments on media coverage of China problems

GSK comments on media coverage of China problems

30-06-2014

UK pharma giant GlaxoSmithKline, already the subject of allegations and investigations of wrongful marketing…

ChinaGlaxoSmithKlineManagementMarkets & MarketingPharmaceutical

NicOx launches commercial operations in Germany

30-06-2014

Ophthalmology-focused French biotech firm NicOx has today announced the launch of its German operations.

AdenoPlusBiotechnologyGermanyManagementMarkets & MarketingNicOxOphthalmicsXailin

Global pharma has significant opportunities for deeper engagement with payers but contingent on restoring trust

09-05-2014

New survey research finds that the majority payers in the USA and Europe believe that drug adherence…

EuropeManagementMarkets & MarketingPharmaceuticalPricingUSA

Actavis opens new Asia Pacific regional headquarters in Singapore

03-04-2014

Ireland-headquartered generics major Actavis has officially opened its new regional office in Singapore…

ActavisAsia-PacificGenericsManagementMarkets & Marketing

Takeda re-aligns marketing system in Japan

24-02-2014

Japan’s largest drugmaker Takeda Pharmaceutical says it decided to re-align its marketing system in…

Asia-PacificJapanManagementMarkets & MarketingPharmaceuticalTakeda Pharmaceuticals

Exclusive: Changing pharma marketplace means new dynamics to deal with, says Mundipharma executive

11-02-2014

The pharmaceutical market is changing, says Georg Toufar, chief marketing officer of Mundipharma International,…

InterviewsManagementMarkets & MarketingMundipharmaPharmaceutical

Majority of pharmaceutical companies centralize market access activities

26-12-2013

A new pharmaceutical benchmarking study found that 53% of surveyed companies centralize their market…

ManagementMarkets & MarketingPharmaceutical

Takeda sets sights on Israeli pharma market, with new subsidiary

Takeda sets sights on Israeli pharma market, with new subsidiary

18-12-2013

Through a European subsidiary, Japan’s largest drugmaker Takeda Pharmaceuticals today announced further…

ManagementMarkets & MarketingPharmaceuticalRest of the WorldTakeda Pharmaceuticals

GlaxoSmithKline to ditch sales target-based compensation, change other global marketing practices

GlaxoSmithKline to ditch sales target-based compensation, change other global marketing practices

17-12-2013

In the wake of the bribery scandal in China, as well as a record-breaking $3 billion fine in the USA…

GlaxoSmithKlineGlobalManagementMarkets & MarketingPharmaceutical

Japan market entry challenges – by P Reed Maurer

Japan market entry challenges – by P Reed Maurer

14-11-2013

Not long ago, the last word in the title would have been obstacles rather than challenges, says P Reed…

Asia-PacificManagementMarkets & MarketingPharmaceutical

Eisai to double Belviq sales force by December

Eisai to double Belviq sales force by December

15-10-2013

Eisai’s US subsidiary will increase its force for the obesity drug Belviq to around 400 representatives…

Arena PharmaceuticalsBelviqEisaiManagementMarkets & MarketingMetabolicsNorth AmericaPharmaceutical

Ono sets up subsidiary in South Korea

14-10-2013

Japanese drugmaker Ono Pharmaceutical has decided to establish a new fully owned subsidiary in South…

Asia-PacificManagementMarkets & MarketingPharmaceutical

GlaxoSmithKline could be considering quitting China, says BBC editor

06-09-2013

For most multinational companies, it is a no-brainer that they have to be big in China, if their global…

Asia-PacificGlaxoSmithKlineLegalManagementMarkets & MarketingPharmaceutical

Almirall sets up new affiliate to support Canadian product launches

06-09-2013

Spain's largest pharma company, Almirall (ALM: MC) has continued its expansion with the launch of a new…

AlmirallManagementMarkets & MarketingNorth AmericaPharmaceuticalTudorza Genuair

Study highlights the steps to shape effective counter-generics strategies

23-08-2013

More than half of pharmaceutical companies - and 71% of the largest (top 10) companies - maintain a dedicated…

GenericsManagementMarkets & MarketingPatents

Briefs: Pfizer $142 million fine upheld; Bristol-Myers shuts Amylin facility

05-04-2013

The US Court of Appeals in Boston has upheld a $142.1 million damage award to Kaiser Foundation Health…

AmylinBristol-Myers SquibbLegalManagementMarkets & MarketingNeurontinNorth AmericaPfizerPharmaceutical

Top strategic priorities for Big Pharma marketing and sales execs in 2013; Accenture survey

26-03-2013

Senior sales and marketing executives of large US pharmaceutical companies - with corporate revenues…

ManagementMarkets & MarketingNorth AmericaPharmaceutical

Takeda expands Latin America footprint with new subsidiary in Ecuador

21-03-2013

Japan's largest drugmaker Takeda Pharmaceuticals (TYO: 4502) says it is expanding its presence in Latin…

ManagementMarkets & MarketingPharmaceuticalSouth AmericaTakeda Pharmaceuticals

Succeeding in Japan's pharma market - by P Reed Maurer

21-02-2013

It appears some Western pharma executives and their consultants cannot grasp the reality of Japan's pharma…

Asia-PacificManagementMarkets & MarketingPharmaceutical

Stada Arz extends generics deal with Omega Pharma; Omega appointments

03-02-2013

German drugmaker Stada Arzneimittel's (SAZ: GR) Belgian subsidiary, Eurogenerics, and the pharmaceutical…

EuropeGenericsManagementMarkets & MarketingOmega PharmaPharmaceuticalSTADA Arzneimittel

Watson Pharma now trading as Actavis; Dr Reddy's debuts generic Clarinex Reditabs in USA

28-01-2013

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) announced last week that the company has adopted…

ActavisClarinex ReditabsDr Reddy's LaboratoriesFinancialGenericsManagementMarkets & MarketingWatson Pharmaceuticals

Daiichi Sankyo and Ranbaxy combine business operations in Thailand

16-01-2013

Japanese pharma major Daiichi Sankyo (TYO: 4568) and its 64%-owned affiliate Ranbaxy Laboratories (AB:…

Asia-PacificDaiichi SankyoGenericsManagementMarkets & MarketingPharmaceuticalRanbaxy Laboratories

Winners in Japan's Pharma market, by P Reed Maurer

20-11-2012

The difference between winning or losing in Japan's pharma market has enormous strategic implications…

Asia-PacificManagementMarkets & MarketingPharmaceuticalResearch

Drugmakers spend an average $237,000 per medical science liaison in the USA

31-10-2012

US-based drug companies spend an average $237,000 on each of their medical science liaisons (MSLs), but…

BiotechnologyGlobalManagementMarkets & MarketingPharmaceutical

1 to 25 of 32 results

Back to top